Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Jie Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Yao(Central South University), Youling Gong(Sichuan University), Caicun Zhou(Tongji University), Guohua Yu(Qingdao University), Kaihua Lu(Jiangsu Province Hospital), Liyan Jiang(Southwest University), Chengping Hu(Central South University), Wei Shi(Jiangsu Hengrui Medicine (China)), Xiaoling Li(Southwest University), Quan Liu(Jiangnan University), Qiming Wang(Hunan Cancer Hospital), Xiaojing Zhang(Southwest University), Zhiyong He(Albert Einstein College of Medicine), Jun Zhao(Beijing Institute of Technology), Ben Zhang(Vanderbilt University), Ying Cheng(First Affiliated Hospital of Xi'an Jiaotong University), Runxiang Yang(Kunming Medical University), Xuhong Min(Xi'an Chest Hospital), Fei Xu(Key Laboratory of Guangdong Province), Yong Fang(Tongji Hospital), Xingya Li(Zhengzhou University), Jingxun Wu(First Affiliated Hospital of Xiamen University), Yunpeng Liu(Shenyang Institute of Automation), Lejie Cao(University of Science and Technology of China), Gongyan Chen(Harbin Medical University), Wenxiu Yao(Sichuan Cancer Hospital), Yun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenhua Zhao(Shandong University), Xingxiang Xu(Northern Jiangsu People's Hospital)
Cited by 417
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578